ADIM
IIIV icon

Alpha DNA Investment Management’s i3 Verticals IIIV Stock Holding History

Alpha DNA Investment Management’s Portfolio IIIV Stock Details IIIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-38,772
Closed -$969K – 174
2022
Q2 		$969K Buy
+38,772
New +$978K 0.83% 70

Other funds holding IIIV

GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
CC
Crosslink Capital Menlo Park, California $1.02B AUM 9.21% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Alpha DNA Investment Management's IIIV Position: Q3 2022 in Review

Alpha DNA Investment Management sold out of i3 Verticals (IIIV) in Q3 2022, closing a stake of 38,772 shares — an estimated $969K sold.

Alpha DNA Investment Management first reported a position in IIIV in Q2 2022 and held it in 1 quarter. The position peaked at $969K in Q2 2022. 130 funds tracked by Wall St. Rank hold IIIV as of Q3 2022.

  • Alpha DNA Investment Management reported no remaining i3 Verticals position as of Q3 2022 after selling out during the quarter.
  • Alpha DNA Investment Management sold 38,772 i3 Verticals shares in Q3 2022, an estimated $969K.
  • Alpha DNA Investment Management first reported a position in i3 Verticals in Q2 2022 and held it in 1 quarter.
  • Alpha DNA Investment Management's i3 Verticals position peaked at $969K in Q2 2022.
  • 130 funds tracked by Wall St. Rank held i3 Verticals as of Q3 2022.

Based on Alpha DNA Investment Management's 13F filing for Q3 2022, filed 15 Nov 2022.